Thrombotic Microangiopathy Associated with Intravenous Injection of Opana ER: University Medical Center Case Series

Journal Title: Journal of Case Reports and Studies - Year 2014, Vol 2, Issue 1

Abstract

In response to the rapidly rising intravenous opioid abuse epidemic, the United States Food and Drug Administration is currently promoting the development of prescription opioid tablets that are specifically formulated to deter abuse. Opana ER (Endo Pharmaceuticals) recently underwent reformulation to include a crush-resistant coating. Only recently described, illicit intravenous injection of reformulated Opana ER is associated with a distinctive clinical syndrome of thrombotic microangiopathy. Ten patients with the appropriate history and presenting symptoms were identified within an 8 month interval (July 2012 through February 2013) at the University of Tennessee Medical Center (UTMC) Knoxville with ICD-9 code of 446.6 (thrombotic microangiopathy) by electronic search. Review of laboratory data, electronic medical records, blood product usage, and total hospital admission charges were compiled for these individual patients. We report the clinicopathologic findings and correlating laboratory data for a group of patients presenting with thrombotic microangiopathy and documented recent history of intravenous Opana ER injection. We also report the economic impact and effect on blood product utilization by this study group.

Authors and Affiliations

Christopher T. Clark

Keywords

Related Articles

Cardiac Tamponade and Splenic Littoral Cell Angioma: An Unusual Presentation of a Very Rare Disease

Littoral cell angioma (LCA) is a rare benign vascular splenic tumor that can evolve, potentially, into a malignant form. It can be found incidentally in the majority of cases during ultrasound (US) or other imaging exams...

How Digital and Physical Care Team Interaction Affect Processing Times: A Case Study of Hospitalists

Importance: Hospitalist physicians face increasing pressure to maximize productivity while maintaining high quality of care. Their success, however, depends on the effective exchange of information among a patient’s care...

External Jugular Vein Aneurysm with Thrombus Presenting as Neck Mass: A Case Report (Rare Case)

External jugular vein aneurysm with thrombosis presenting as neck swelling is a rare clinical entity and rarely encountered in routine clinical practice in otorhinolaryngology. We present a case of a 52-year-old female w...

Primary Large Hydatid Cyst of The Neck

Hydatid cyst in the head and neck is very rare. We report the exceptional case of a 9-year-old female child presenting with a hydatid cyst in the posterior cervical region. The diagnosis of hydatid cyst is made mainly wi...

A Case Report of Atrial Myxoma presenting with Cardioembolic Stroke and treated with Intravenous Thrombolytic Therapy

Background: Cardiac myxomas are a potential source of emboli to the brain and elsewhere in the vascular tree. Myxomas are the most common benign primary cardiac tumor in adults. The commonest location of cardiac myxomas...

Download PDF file
  • EP ID EP582407
  • DOI 10.15744/2348-9820.1.401
  • Views 88
  • Downloads 0

How To Cite

Christopher T. Clark (2014). Thrombotic Microangiopathy Associated with Intravenous Injection of Opana ER: University Medical Center Case Series. Journal of Case Reports and Studies, 2(1), 1-5. https://europub.co.uk/articles/-A-582407